Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study

NCT07275697 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation (AF)
Obesity & Overweight

Interventions

DRUG: Semaglutide 2.4 mg
BEHAVIORAL: Standard medical treatment

Sponsor

Emma Svennberg

Collaborators

[object Object]